Pharmaceutical News

RSS

Report cites 15 New York State HMOs for setting consumer restrictions on prescription drugs to boost profits

Some HMOs in New York state are restricting patients' access to so-called single-source drugs, brand-name medications for specific ailments that do not have lower-cost generic versions, according to a report released on Sunday, the New York Daily News reports.

20 May 2008

FDA approves Entereg (alvimopan) to restore bowel function

The U.S. Food and Drug Administration approved Entereg (alvimopan) today to accelerate the restoration of normal bowel function in patients 18 years and up who have undergone partial large or small bowel resection surgery. Entereg will be used in hospitalized patients who can receive no more than 15 doses.

20 May 2008

Stiff competition for Viagra in the pipeline

Scientists in Scotland are in the process of developing a drug which could offer stiff competition to the drug Viagra.

20 May 2008

Industry group letter indicates qualified aupport for bill to allow approval of generic biotechnology medications

The Biotechnology Industry Organization has issued a letter to Reps. Anna Eshoo (D-Calif.) and Joe Barton (R-Texas) to indicate qualified support for a bill (HR 5629) that they have introduced to allow FDA to approve generic biotech medications, CQ HealthBeat reports (McCarthy, CQ HealthBeat, 5/16).

19 May 2008

National Community Pharmacists Association to launch ad campaign to lobby lawmakers for policy changes

The National Community Pharmacists Association this week plans to launch a new advertising campaign that asks lawmakers to address two policies that the group maintains has or will result in closures of community pharmacies, CongressDaily reports. As part of the launch of the campaign, about 500 community pharmacists and independent pharmacy owners will visit Washington, D.C.

19 May 2008

Taiwan approves WTO amendment allowing countries to export lower-cost versions of antiretrovirals, other drugs to developing countries

Taiwan's legislative body the Yuan on Thursday approved the first reading of a proposed World Trade Organization amendment that would allow pharmaceutical companies to make lower-cost versions of generic antiretroviral drugs, as well as drugs for malaria and other diseases, to sell to developing countries, the CNA/Taipei Times reports.

19 May 2008

Spectrum Pharmaceuticals to present data on Ortataxel in breast cancer at major oncology meeting

Spectrum Pharmaceuticals, Inc., will present Phase 2 data on ortataxel at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting being held May 30 to June 3, 2008 at the McCormick Place Convention Center in Chicago, Illinois.

19 May 2008

Nasal gel to fight superbug MRSA

British scientists are well on the way to developing a new drug to fight the 'superbug' Methicillin-resistant Staphylococcus aureus (MRSA).

19 May 2008

First pre-pandemic bird flu vaccine available in Europe

The approval for a licence from the European Commission will place Glaxo ahead of rivals in the vaccine fields and the company says it has already received orders from some governments such as the U.S., Switzerland and Finland.

19 May 2008

Cancer Research UK and AstraZeneca announce innovative deal for promising anti-cancer compound

Cancer Research UK and Cancer Research Technology (CRT) - the charity's development and commercialisation arm - today announced an innovative new arrangement to progress into clinical development a potential anti-cancer compound from AstraZeneca.

19 May 2008

Schering-Plough extends antibody aliance with MorphoSys

MorphoSys AG announced today that Schering-Plough Corporation has decided to extend the current collaboration between the two companies for one year.

19 May 2008

51% of insured U.S. residents regularly take prescription drugs for chronic illnesses

Fifty-one percent of insured U.S. residents last year took one or more prescription drugs for chronic diseases, compared with 50% in the previous four years and 47% in 2001, according to a report released last Tuesday by Medco Health Solutions, the AP/Houston Chronicle reports.

19 May 2008

Aridol authorised for sale in Germany

Pharmaxis Ltd today announced that it has received national approval to market Aridol in Germany.

19 May 2008

New hay fever jab promises year long relief for sufferers

Relief is in sight for millions of hay fever sufferers with the promise of a jab, which lasts for a year, that significantly reduces symptoms.

15 May 2008

Remaining stocks of Trasylol removed

On Nov. 5, 2007, the U.S. Food and Drug Administration announced that Bayer Pharmaceuticals Corp. agreed to an FDA-requested marketing suspension of Trasylol, a drug used to control bleeding during heart surgery. At that time, preliminary results from a Canadian study suggested an increased risk for death compared to two other drugs used to control bleeding.

15 May 2008

GenoMed offers its patented treatment to Chinese earthquake victims

GenoMed has announced that it has offered its treatment to physicians caring for victims of the recent earthquake in China.

14 May 2008

Lawmakers criticize agencies for lack of coordination of prescription drug benefits for federal retirees

A lack of coordination between CMS and the Office of Personnel Management on prescription drug benefits for federal retirees has cost those retirees and the federal government as much as $200 million annually, according to a letter sent to the agencies on Monday by two House Democrats, CQ HealthBeat reports.

13 May 2008

Hawaii Legislature overrides Gov. Lingle's veto of prescription drug importation program

Hawaii lawmakers last week overrode Gov. Linda Lingle's (R) veto of a bill that will enroll the state in I-SaveRx, a program that allows residents to purchase lower-cost prescription drugs from other countries, the AP/Honolulu Advertiser reports.

13 May 2008

Canadian drug company awarded Rwandan contract to provide combination antiretroviral

Rwanda recently accepted a bid from the Toronto-based generic drug company Apotex to supply its fixed-dose combination antiretroviral drug Apo-triAvir to the country, the Toronto Star reports (Toronto Star, 5/9).

13 May 2008

Barr announces approval of generic version of Yasmin (drospirenone and ethinyl estradiol)

Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) to manufacture and market a generic version of Yasmin (drospirenone and ethinyl estradiol), an oral contraceptive product manufactured and marketed by Bayer Schering Pharma, AG.

9 May 2008

Pharmaceutical News

Report cites 15 New York State HMOs for setting consumer restrictions on prescription drugs to boost profits

FDA approves Entereg (alvimopan) to restore bowel function

Stiff competition for Viagra in the pipeline

Industry group letter indicates qualified aupport for bill to allow approval of generic biotechnology medications

National Community Pharmacists Association to launch ad campaign to lobby lawmakers for policy changes

Taiwan approves WTO amendment allowing countries to export lower-cost versions of antiretrovirals, other drugs to developing countries

Spectrum Pharmaceuticals to present data on Ortataxel in breast cancer at major oncology meeting

Nasal gel to fight superbug MRSA

First pre-pandemic bird flu vaccine available in Europe

Cancer Research UK and AstraZeneca announce innovative deal for promising anti-cancer compound

Schering-Plough extends antibody aliance with MorphoSys

51% of insured U.S. residents regularly take prescription drugs for chronic illnesses

Aridol authorised for sale in Germany

New hay fever jab promises year long relief for sufferers

Remaining stocks of Trasylol removed

GenoMed offers its patented treatment to Chinese earthquake victims

Lawmakers criticize agencies for lack of coordination of prescription drug benefits for federal retirees

Hawaii Legislature overrides Gov. Lingle's veto of prescription drug importation program

Canadian drug company awarded Rwandan contract to provide combination antiretroviral

Barr announces approval of generic version of Yasmin (drospirenone and ethinyl estradiol)

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News